An interventional study of VR headset and Usual Care in Abortion, First Trimester, Pain Management and Pain After Surgery, sponsored by Study Investigator. Completed at 2 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Study Investigator · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 91 studies in Personal Satisfaction with a site in United States — 6 open to participants now, 8 under way, none of them phase 3. Personal Satisfaction · United States.
Among the 91 studies in Personal Satisfaction with a site in United States, this one is the 55th largest by enrollment of the 80 interventional ones that give a count, is one of 4 that started in 2026, is one of 65 with no phase, and was the 89th registered.
543 studies on the registry are indexed under Personal Satisfaction; 91 are open to participants now.
Browse Personal Satisfaction studies →6 of the 91 studies in Personal Satisfaction with a site in United States are open now. Recruiting first, the newest first:
Avant Health LLC · Sites in United States
Ages 18+
University of Colorado, Denver · Sites in United States
Ages 8–18
Belmont University · Sites in United States
Ages 18+ · Healthy volunteers
Indiana University · Sites in United States
Ages 18+
Oregon Research Behavioral Intervention Strategies, Inc. · Sites in United States
Ages 3–90 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 38 Personal Satisfaction studies recruiting now, 18 (47%) set no upper age limit and 15 (39%) stop at 75 or younger; 8 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
91 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 71 is below the median of 93 across 418 interventional studies indexed under Personal Satisfaction.
Median enrollment 117 across the 80 interventional studies, 83 across the 11 observational. Of the 75 that completed or were terminated, 20 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 91 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Study Investigator as lead sponsor.
Study Investigator has 1 study filed under Personal Satisfaction — fewer than ten, so there is no comparison to draw.
3 of the studies in Personal Satisfaction with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05110729University of Colorado, DenverQuality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury | 2026-11 |
| NCT06992544Brigham and Women's HospitalTrial of Pistachio Consumption in Older Adults | 2027-03 |
| NCT07228299Indiana UniversitySupporting Families in the ICU | 2027-11-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 91 studies in Personal Satisfaction with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn whether use of a virtual reality (VR) headset showing a meditative nature video will help reduce pain and anxiety during a first trimester procedural abortion. Investigators will enroll 72 patients undergoing a first trimester procedural abortion with usual care to manage pain and anxiety compared to use of a VR headset in addition to usual care to see if use of the VR headset will decrease pain and anxiety and increase satisfaction with the procedure.
While procedural abortions are common outpatient procedures, providing optimal pain and anxiety relief during these procedures is challenging. With rapidly developing technological advances, virtual reality (VR) has emerged as a promising modality to help manage pain and anxiety control in the medical field, including obstetrics and gynecology. However, there are no studies evaluating the effect of VR on pain during a procedural abortion.
The goal of this randomized controlled trial is to primarily evaluate whether using a VR headset to display a meditative nature video as a noninvasive, low risk technology may reduce pain and anxiety for patients undergoing a first trimester procedural abortion in an outpatient setting. Investigators will also evaluate factors influencing satisfaction with the procedure. Investigators will compare use of the VR headset with usual care, to usual care only; for a first trimester procedural abortion, usual care includes oral pain medications, local anesthetic medication in the cervix, and verbal reassurance. Participants will be asked to complete a survey before, after, and one week following the procedure to assess pain, anxiety, and overall satisfaction.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Usual care for pain and anxiety management during a first trimester procedural abortion includes oral ibuprofen, intracervical block, and verbal analgesia.
Other: Usual Care
Participants will wear the VR headset during the first trimester procedural abortion, in addition to usual care for pain and anxiety management. The headset will display a meditative nature video throughout the procedure.
Device: VR headset · Other: Usual Care
VR Headset: Meta Quest 3S Meditative nature videos provided via "Guided Meditation VR" app.
Usual care for pain and anxiety management during a first trimester procedural abortion includes oral ibuprofen, intracervical block, and verbal analgesia.
Also known as: Routine care
Pain scores during a first trimester procedural abortion
Pain will be measured on a visual analogue scale during and after the procedural abortion via a REDCap survey. The scale is from 0-100, with 0 being "No pain" and 100 being the "Worst pain of my life". The difference in this score (post-procedure minus pre-procedure) is what will be compared between study arms.
Time frame: Day of enrollment: immediately preprocedure and 15 minutes postprocedure.
Anxiety scores during a first trimester procedural abortion
Anxiety will be measured on a visual analogue scale during and after the procedural abortion via a REDCap survey. The scale is from 0-100, with 0 being "No anxiety or fear" and 100 being the "Worst anxiety or fear of my life". The difference in this score (post-procedure minus pre-procedure) is what will be compared between study arms.
Time frame: Day of enrollment: immediately preprocedure and 15 minutes postprocedure.
Satisfaction with the first trimester procedural abortion
Satisfaction will be assessed on a Likert scale using surveys administered on the day of the procedure and one week after the procedure. A score of 1 = very dissatisfied, and a score of 5 = very satisfied.
Time frame: Day of enrollment (immediately postprocedure) and one week after completion of the procedural abortion.
Plan to share: No — There are currently no plans to share the data, however it is possible we may choose to share the data with other groups or individuals interested in this topic. Should we choose to share, the data will be de-identified and a data use agreement will be executed as needed.
No publications or documents are linked to this record.
Ran from May 2026 to primary completion in Aug 2026, 3 months.
Of 250 non-industry interventional studies with no phase under Personal Satisfaction, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 3 months is below that.
Counting every sponsor, half of 257 studies reached it within 9 months; a quarter within 3 and three quarters within 21.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: primary completion Oct 2026 → Aug 2026 and completion Oct 2026 → Aug 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.